Tokyo, Japan

Nabuya Yanai

This inventor holds 1 USPTO granted patent. Top assignee: Morinaga Milk Industry Co., Ltd.. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nabuya Yanai. Retrieved from https://idiyas.com/inventor/nabuya-yanai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nabuya Yanai: Innovator in Anti-Infective Substances

Introduction

Nabuya Yanai is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of anti-infective substances. His work focuses on utilizing polysaccharides derived from specific bacteria to combat infections.

Latest Patents

Nabuya Yanai holds a patent for a substance having an anti-infective activity. This invention involves a polysaccharide separated from the cell wall of bacteria belonging to the genus Bifidobacterium, specifically Bifidobacterium infantis and Bifidobacterium longum. The polysaccharide is primarily composed of glucose and galactose in a molar ratio of 1:about 2.8. This innovative approach has the potential to enhance the effectiveness of anti-infective treatments.

Career Highlights

Nabuya Yanai is associated with Morinaga Milk Industry Co., Ltd., where he continues to develop his research and inventions. His dedication to innovation in the field of health and nutrition is evident through his work and contributions.

Collaborations

Nabuya collaborates with talented individuals such as Rintaro Nakaya and Minoru Saito. Their combined expertise fosters a productive environment for research and development.

Conclusion

Nabuya Yanai's work in developing anti-infective substances showcases his commitment to advancing health solutions. His innovative patent reflects the potential for significant impact in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…